<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Pivagabine</id>
	<title>Pivagabine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Pivagabine"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Pivagabine&amp;action=history"/>
	<updated>2026-04-27T14:56:22Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Pivagabine&amp;diff=5805543&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Pivagabine&amp;diff=5805543&amp;oldid=prev"/>
		<updated>2024-05-22T15:22:40Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Pivagabine.svg|thumb|Pivagabine.svg]] &amp;#039;&amp;#039;&amp;#039;Pivagabine&amp;#039;&amp;#039;&amp;#039; is a pharmaceutical drug that has been studied for its potential effects on the [[central nervous system]]. It is known for its anxiolytic and neuroprotective properties.&lt;br /&gt;
&lt;br /&gt;
== Pharmacology ==&lt;br /&gt;
Pivagabine works by modulating the levels of [[gamma-aminobutyric acid]] (GABA) in the brain. GABA is the primary inhibitory neurotransmitter in the central nervous system, and its regulation is crucial for maintaining [[neurotransmission]] balance. By influencing GABA levels, Pivagabine can help reduce [[anxiety]] and protect neurons from damage.&lt;br /&gt;
&lt;br /&gt;
== Clinical Uses ==&lt;br /&gt;
Pivagabine has been investigated for its use in treating various conditions, including:&lt;br /&gt;
* [[Anxiety disorders]]&lt;br /&gt;
* [[Depression]]&lt;br /&gt;
* [[Neurodegenerative diseases]]&lt;br /&gt;
&lt;br /&gt;
== Mechanism of Action ==&lt;br /&gt;
The exact mechanism of action of Pivagabine is not fully understood. However, it is believed to enhance the activity of GABA by inhibiting its reuptake and increasing its availability in the synaptic cleft. This leads to a calming effect on the brain and helps in reducing symptoms of anxiety and other related disorders.&lt;br /&gt;
&lt;br /&gt;
== Side Effects ==&lt;br /&gt;
Common side effects of Pivagabine may include:&lt;br /&gt;
* [[Drowsiness]]&lt;br /&gt;
* [[Dizziness]]&lt;br /&gt;
* [[Nausea]]&lt;br /&gt;
* [[Headache]]&lt;br /&gt;
&lt;br /&gt;
== Research and Development ==&lt;br /&gt;
Pivagabine is still under investigation, and more research is needed to fully understand its efficacy and safety profile. Clinical trials are ongoing to determine its potential benefits and risks in various patient populations.&lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
* [[Anxiolytic]]&lt;br /&gt;
* [[Neuroprotection]]&lt;br /&gt;
* [[Gamma-aminobutyric acid]]&lt;br /&gt;
* [[Central nervous system]]&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
== External Links ==&lt;br /&gt;
{{No external links}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Anxiolytics]]&lt;br /&gt;
[[Category:Neuroprotective agents]]&lt;br /&gt;
[[Category:Gamma-aminobutyric acid]]&lt;br /&gt;
[[Category:Central nervous system]]&lt;br /&gt;
&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>